ArticleJournal of clinical medicine2019

Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial.

Hiroyuki Hirai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.